<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abciximab was administered intravenously to three patients to treat <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> associated with atherosclerotic stenosis of a supra-aortic artery </plain></SENT>
<SENT sid="1" pm="."><plain>In two cases, the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> had been identified on a previous angiography more than a week before treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Successful thrombolysis was achieved with abciximab in <z:hpo ids='HP_0000001'>all</z:hpo> three cases </plain></SENT>
<SENT sid="3" pm="."><plain>In this small series, abciximab had a thrombolytic effect on established <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> that were refractory to previous antithrombotic treatment attempts </plain></SENT>
</text></document>